A significant number of studies have pointed out the importance of SOCS proteins that can modulate the JAK/STAT pathway and are emerging therapeutic targets in the treatment of AD and other inflammation-related pathologies [45,48]. The gene discussed is CISH; the disease is Alzheimer disease.